Welcome to the SEER Inquiry System (SINQ). SINQ is a collection of questions that cancer registrars have had while coding cancer cases. Click Search to look for specific questions or to select questions for a Report.

Recent Questions
1 to 10 of 2008    Next 10 >    Last >>
Add to Report ID Question Status Last Updated
20180016

Primary site--Pancreas: Is the uncinate process of the pancreas coded to C259, C250, or C257?

Final Mar 30 2018
20180015

Histology--Ovary: What is the correct ICD-O-3 histology code for sertoliform endometrioid carcinoma of the ovary?

Final Mar 30 2018
20180014

Reportability/Histology--Brain and CNS: Is multinodular and vacuolating neuronal tumor of the cerebrum reportable, and if so, is the histology coded as 9492/0?  See Discussion.

Final Mar 30 2018
20180013

Reportability--Brain and CNS: Are tuberous sclerosis cancers found in the brain reportable?  See Discussion.

Final Mar 30 2018
20180012

First course of treatment:  What is the correct code to use for allogenic stem cell transplant?

Final Mar 30 2018
20180010

Diagnostic confirmation--Heme & Lymphoid Neoplasms: Is Diagnostic Confirmation coded as 5 (positive laboratory test/ marker study) or code 8 (clinical diagnosis only) for a case that has a positive JAK2 mutation, and based on the results of the JAK2, the physician diagnosed the patient with polycythemia vera?  There were no blood smears or bone marrow biopsies done.

Final Mar 02 2018
20180009

Reportability--Head & Neck: Is dentinoameloblastoma reportable, and if so, what is the correct histology code?  See Discussion.

Final Feb 28 2018
20180008

MP/H Rules/Multiple primaries--Thyroid: Is medullary carcinoma of the right lobe of the thyroid, with foci of papillary microcarcinoma in both lobes, one primary with mixed histology (8347/3) or two separate primaries?

Final Feb 20 2018
20180007

Multiple primaries/Primary site--Heme & Lymphoid Neoplasms:  Are plasmacytomas in thyroid and laryngeal masses one primary based on rule M2, abstract a single primary when there is a single histology? If so, what is the primary site?  See Discussion.

Final Feb 08 2018
20180006

MP/H Rules/Histology--Breast:  Should encapsulated papillary carcinoma of the breast with a separate focus of ductal carcinoma in situ be coded as 8050/2 (papillary carcinoma) and staged as in situ?  See Discussion.

Final Jan 29 2018
Next 10 >